The Sidney Kimmel Comprehensive Cancer Center
- Country
- 🇺🇸United States
- Ownership
- Private, Subsidiary
- Employees
- -
- Market Cap
- -
Trial of Rucaparib in Patients With Metastatic Hormone-Sensitive Prostate Cancer Harboring Germline DNA Repair Gene Mutations
- First Posted Date
- 2018-01-29
- Last Posted Date
- 2024-10-16
- Target Recruit Count
- 12
- Registration Number
- NCT03413995
- Locations
- 🇺🇸
Johns Hopkins Hospital, Baltimore, Maryland, United States
🇺🇸Weill Cornell Medical College, New York, New York, United States
Radiosurgical Hypophysectomy for Bone Metasteses Pain
- Conditions
- Bone Metastases
- Interventions
- Radiation: radiosurgical hypophysectomy
- First Posted Date
- 2017-12-19
- Last Posted Date
- 2024-06-07
- Target Recruit Count
- 16
- Registration Number
- NCT03377517
- Locations
- 🇺🇸
The Sidney Kimmel Comprehsensive Cancer Center at Johns Hopkins, Baltimore, Maryland, United States
Allogeneic Myeloma GM-CSF Vaccine With Lenalidomide in Multiple Myeloma Patients in Complete or Near Complete Remission
- Conditions
- Multiple Myeloma
- Interventions
- Other: Placebo Prevnar13Other: Placebo GM-CSF Vaccine
- First Posted Date
- 2017-12-18
- Last Posted Date
- 2024-12-13
- Target Recruit Count
- 54
- Registration Number
- NCT03376477
- Locations
- 🇺🇸
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, Maryland, United States
Role of Pharyngeal High Resolution Manometry and Impedance in Swallow Function of Head and Neck Cancer Patients
- Conditions
- Head and Neck CancerDysphagia
- Interventions
- Diagnostic Test: pHRMi
- Locations
- 🇺🇸
SKCCC at Johns Hopkins (East Baltimore Campus), Baltimore, Maryland, United States
🇺🇸Suburban Hospital, Bethesda, Maryland, United States
Radiopaque Hydrogel in Patients Undergoing Radiotherapy for Pancreatic Cancer
- Conditions
- Pancreatic Adenocarcinoma
- Interventions
- Device: TraceIT tissue marker injection
- First Posted Date
- 2017-10-11
- Last Posted Date
- 2024-04-25
- Target Recruit Count
- 6
- Registration Number
- NCT03307564
- Locations
- 🇺🇸
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, Maryland, United States
Feasibility and Efficacy of Neoadjuvant Cabozantinib Plus Nivolumab (CaboNivo) Followed by Definitive Resection for Patients With Locally Advanced Hepatocellular Carcinoma (HCC)
- Conditions
- Locally Advanced Hepatocellular Carcinoma
- Interventions
- First Posted Date
- 2017-10-03
- Last Posted Date
- 2023-03-28
- Target Recruit Count
- 15
- Registration Number
- NCT03299946
- Locations
- 🇺🇸
Sidney Kimmel Comprehensive Cancer Center, Baltimore, Maryland, United States
5 Fraction Stereotactic Radiosurgery With Temozolomide for Glioblastoma Multiforme
- First Posted Date
- 2017-09-25
- Last Posted Date
- 2021-11-19
- Target Recruit Count
- 3
- Registration Number
- NCT03291990
- Locations
- 🇺🇸
Sibley Hospital, Washington, District of Columbia, United States
🇺🇸Suburban Hospital, Washington, District of Columbia, United States
🇺🇸SKCCC at Johns Hopkins (East Baltimore), Baltimore, Maryland, United States
Involving Family to Improve Communication in Breast Cancer Care
- Conditions
- Active Breast Cancer Treatment
- Interventions
- Other: Usual CareOther: Checklist, MyChart, OpenNotes
- First Posted Date
- 2017-09-14
- Last Posted Date
- 2021-03-19
- Target Recruit Count
- 132
- Registration Number
- NCT03283553
- Locations
- 🇺🇸
Johns Hopkins Kimmel Cancer Center - Medical Oncology, Baltimore, Maryland, United States
🇺🇸Johns Hopkins Kimmel Cancer Center at Green Spring Station - Medical Oncology, Lutherville, Maryland, United States
A Clinical Trial of Entinostat in Combination With Nivolumab for Patients With Previously Treated Unresectable or Metastatic Cholangiocarcinoma and Pancreatic Adenocarcinoma
- Conditions
- Pancreatic CancerUnresectable Pancreatic CancerMetastatic CholangiocarcinomaMetastatic Pancreatic CancerCholangiocarcinomaUnresectable Cholangiocarcinoma
- Interventions
- First Posted Date
- 2017-08-15
- Last Posted Date
- 2024-01-09
- Target Recruit Count
- 44
- Registration Number
- NCT03250273
- Locations
- 🇺🇸
Sidney Kimmel Comprehensive Cancer Center, Baltimore, Maryland, United States
Clinical Trial of Combined Fostamatinib and Paclitaxel in Ovarian Cancer
- Conditions
- Ovarian Cancer
- Interventions
- First Posted Date
- 2017-08-11
- Last Posted Date
- 2024-10-24
- Target Recruit Count
- 27
- Registration Number
- NCT03246074
- Locations
- 🇺🇸
Sibley Memorial Hospital, Washington, District of Columbia, United States
🇺🇸University of Pennsylvania Health System, Philadelphia, Pennsylvania, United States
🇺🇸Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, Maryland, United States